We’re proud to welcome Ed Smith, RPh, MBA, BCMAS, to the Board of Directors at NanoDetection Technology™!

Ed is a seasoned healthcare and life sciences executive with deep expertise across diagnostics, pharmaceuticals, and health systems. He brings a rare blend of clinical insight and strategic leadership—spanning commercialization, market development,​ interdisciplinary operations, and strategic alliances—that will be instrumental as we advance our proprietary chemiluminescence-based platform for infectious disease detection in human and veterinary health.

We’re thrilled to have Ed on board and look forward to the impact of his contributions.